OMX Nordic 40
2.341,43
PKT
-6,40
PKT
-0,27
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.08.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 20.08.25 | Volvo (B) Buy | UBS AG | |
| 19.08.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.08.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 19.08.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 14.08.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Halten | DZ BANK | |
| 07.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Neutral | UBS AG | |
| 05.08.25 | AstraZeneca Buy | UBS AG | |
| 05.08.25 | Novo Nordisk Neutral | UBS AG | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 04.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 01.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | Hennes Mauritz (H M, H&M) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.07.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.07.25 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.07.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | AstraZeneca Buy | UBS AG |